Company intelligence / Profile preview

Anshi Pharmaceutical (Zhongshan) Inc.

Zhongshan City, Guangdong Sheng, Chinamarketscreener.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Anshi Pharmaceutical develops innovative small molecule drugs targeting chronic diseases such as NASH, obesity, and osteoporosis. The company has completed Phase II trials for synthetic bear bile acid and has launched several major products in China including ursodeoxycholic acid. It also produces calcium supplements and nutraceuticals. Its manufacturing facilities have been inspected by both the US FDA and China's NMPA.[1][3] Clinical results include successful completion of a Phase II trial comparing their ursodeoxycholic acid oral suspension to Ursofalk®.[2]

Therapeutic areas: GastroenterologyEndocrinologyOphthalmologyInfectious Diseases
Modalities: Small molecules[1]Herbal medicines[2]Oral solid and lyophilized injectables[1]
Industry: Biotech

Drug pipeline

5 assets

AR231

Preclinical

4 more assets in the full pipeline.

Request access →

Partnerships

Strategic investment in Rabome Inc.; collaborations with Beijing Honghui Institute of Pharmaceutical Research; Tianjin Institute of Pharmaceutical Research; A&Z Pharmaceutical Inc as joint venture partner/investor.[1][4]

Beyond the preview

Go deeper on Anshi Pharmaceutical (Zhongshan) Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anshi Pharmaceutical (Zhongshan) Inc..

Explore the full profile